Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
Wang N, Fan Y, Yuan CM, Song J, Yao Y, Liu W, Gajendran B, Zacksenhaus E, Li Y, Liu J, Hao XJ, Ben-David Y.
Wang N, et al. Among authors: liu j, liu w.
BMC Cancer. 2019 Aug 2;19(1):764. doi: 10.1186/s12885-019-5914-8.
BMC Cancer. 2019.
PMID: 31375085
Free PMC article.